/newsroom/taxonomy/term/3537/all en /newsroom/channels/news/environmental-activists-high-risk-violence-and-assassination-322997 <p>Activists protesting against environmental injustices around the world suffer from high rates of criminalization, physical violence and murder, according to a study published this week in <a href="https://doi.org/10.1016/j.gloenvcha.2020.102104"><i>Global Environmental Change</i></a>. Indeed, despite the fact that they primarily use nonviolent forms of protest, activists are victims of violence in 18% of environmental conflicts, and of murder in 13% of these conflicts. When Indigenous Peoples are involved, violence is especially frequent.</p> Wed, 24 Jun 2020 22:00:29 +0000 amelia.souffrant@mail.mcgill.ca 218961 at /newsroom /newsroom/channels/news/ctv-news-loneliness-can-directly-impair-immune-system-increase-risk-death-study-322840 <p>The findings, published in the journal Trends in Cognitive Sciences earlier in June, show how social isolation can negatively affect the health of the brain as well as the immune system.“Social isolation, or a lack of social opportunity, gives rise to a sense of loneliness. Directly or indirectly, this feeling has many wide-ranging consequences for our psychological well-being as well as our physical health, even our longevity,” the study states.</p> Wed, 17 Jun 2020 22:42:46 +0000 amelia.souffrant@mail.mcgill.ca 217106 at /newsroom /newsroom/channels/news/why-do-some-non-smokers-get-copd-while-many-heavy-smokers-dont-322660 <p>Smoking is the best-known risk factor for chronic obstructive pulmonary disease (COPD), a debilitating lung condition that can severely limit a person’s day-to-day activities. But curiously, only a minority of lifelong smokers develops the disease, while non-smokers represent more than 25% of all COPD cases. A new study published today in <i>The Journal of the American Medical Association </i>suggests that a developmental mismatch between airway and lung size—a condition called dysanapsis—could answer why.</p> Tue, 09 Jun 2020 12:55:51 +0000 amelia.souffrant@mail.mcgill.ca 215519 at /newsroom /newsroom/channels/news/national-post-hydroxychloroquine-study-finds-drug-no-more-effective-placebo-322607 <p>Hydroxychloroquine is not effective in preventing the development of COVID-19 in people exposed to the novel coronavirus, a new study involving Canadian researchers concludes. The results are published today in the New England Journal of Medicine. The clinical trial was led in Canada by Dr. Todd Lee and <strong>Dr. Emily McDonald of the Research Institute of the 91���� Health Centre</strong>, in conjunction with partners at the University of Manitoba and University of Alberta. The Canadian research is co-ordinated with a large study by Dr.</p> Thu, 04 Jun 2020 23:46:32 +0000 amelia.souffrant@mail.mcgill.ca 214667 at /newsroom